Novel mutation in STXBP2 prevents IL-2-induced natural killer cell cytotoxicity.

Saltzman, Rushani W; Monaco-Shawver, Linda; Zhang, Kejian; Sullivan, Kathleen E; Filipovich, Alexandra H; Orange, Jordan S · J Allergy Clin Immunol · 2012

case_report · Level V

Where this comes from

Abstract

We have identified dizygotic twins with a novel syntaxin-binding protein 2 (STXBP2) mutation, where cytotoxicity cannot be restored with IL-2. This defines STXBP2 as an absolute requirement for NK cell cytotoxic function.

Medical subject headings